Human interprets the integral and transversal training model of the Campus Bio-Medico University of Rome, which combines scientific preparation, a multidisciplinary approach, and attention to the ...
In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results